REGENEXX: NEW STEM CELL SAFETY PAPER
Source: ryortho
Colorado-based Regenexx has, according to the June 15, 2016 news release, published “the world’s largest stem cell safety paper. The study was published in International Orthopaedics (March 30, 2016). The purpose of the study was to determine if mesenchymal-stem-cell-based therapies [MSC] are safe procedures when used for orthopedic degenerative conditions or injuries, and it included 2,372 subjects who received a total of 3,012 stem cell injection procedures.